丽珠医药(01513.HK)8月25日耗资299.92万元回购7.23万股A股
Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a share buyback on August 25, 2023, spending 2.9992 million yuan to repurchase 72,300 A-shares [1]
Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a share buyback on August 25, 2023, spending 2.9992 million yuan to repurchase 72,300 A-shares [1]